Recombinant Human Slit2 (aa 26-1118) Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 8616-SL
Key Product Details
Source
Accession #
Structure / Form
Conjugate
Applications
Product Specifications
Source
Gln26-Val1118, with a C-terminal 6-His tag
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
Recombinant Human Slit2 immobilized at 2.5 μg/mL is able to significantly induce neurite outgrowth.
Formulation, Preparation and Storage
8616-SL
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS, NaCl and Ethylene Glycol. |
Reconstitution |
Reconstitute at 250 μg/mL in water.
|
Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: Slit2
Slit2 has been shown to bind to multiple receptors including ROBO-1, -2, -3, and -4, Laminin-1, DAN, Gremlin, and Glypican-1 (1, 6-8). Depending upon the target, Slit2 can promote a number of diverse effects. Slit2 regulates axon guidance by binding to ROBO receptors and initiating axon repulsion (1, 5, 9-12). Slit2 has also been shown to induce growth cone collapse, inhibit oligodendrocyte precursor cell migration, and promote axon elongation, branch formation, and fasciculation (5, 13-16). Additionally, Slit2-N and Slit2-C have been shown to have distinct activities. Slit2-N binds to ROBO-1 and repels motor axon migration, while Slit2-C binds to Glypican-1 and promotes motor axon migration (5). Outside the nervous system, Slit2 plays a role in a wide range of biological processes including cell adhesion and migration, tumor progression and metastasis, angiogenesis, lymphangiogenesis, HIV-1 replication, platelet function and thrombus formation, and stem cell senescence (1, 8, 17-30).
References
- Ypsilanti, A.R. et al. (2010) Development 137:1939.
- Itoh, A. et al. (1998) Brain Res. Mol. Brain Res. 62:175.
- Holmes, G.P. et al. (1998) Mech. Dev. 79:57.
- Chédotal, A. (2007) Adv. Exp. Med. Biol. 621:65.
- Nguyen Ba-Charvet, K.T. et al. (2001) J. Neurosci. 21:4281.
- Nguyen-BA-Charvet, K.T. et al. (2001) Mol. Cell. Neurosci. 17:1048.
- Hagino, S. et al. (2003) Glia 42:130.
- Chen, B. et al. (2004) J. Immunol. 173:5914.
- Yuan, W. et al. (1999) Dev. Biol. 212:290.
- Erskine, L. et al. (2000) J. Neurosci. 20:4975.
- Shu, T. et al. (2003) J. Neurosci. 23:8176.
- Kim, M. et al. (2014) Neural Dev. 9:17.
- Wang, K.H. et al. (1999) Cell 96:771.
- Wong, E.V. et al. (2004) J. Neurobiol. 59:66.
- Liu, X. et al. (2012) J. Biol. Chem. 287:17503.
- Jaworski, A. and Tessier-Lavigne, M. (2012) Nat. Neurosci. 15:367.
- Guan, H. et al. (2003) J. Immunol. 171:6519.
- Liu, D. et al. (2006) Circ. Res. 98:480.
- Prasad, A. et al. (2007) J. Leukoc. Biol. 82:465.
- Tole, S. et al. (2009) J. Leukoc. Biol. 86:1403.
- Kim, H.K. et al. (2008) Neoplasia 10:1411.
- Prasad, A. et al. (2008) J. Biol. Chem. 283:26624.
- Tseng, R.C. et al. (2010) Cancer Res. 70:543.
- Alajez, N.M. et al. (2011) Cancer Res. 71:2381.
- Zhang, Q.Q. et al. (2015) Oncotarget 6:3123.
- Dunaway, C.M. et al. (2011) Mol. Cell. Biol. 31:404.
- Yang, X.M. et al. (2010) Biochem. Biophys. Res. Commun. 396:571.
- Anand, A.R. et al. (2011) AIDS 25:2105.
- Patel, S. et al. (2012) Circulation 126:1385.
- Harburg, G. et al. (2014) Stem Cell Reports 3:385.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional Slit2 Products
Product Documents for Recombinant Human Slit2 (aa 26-1118) Protein, CF
Product Specific Notices for Recombinant Human Slit2 (aa 26-1118) Protein, CF
For research use only